Article
Peptides At The Crossroads: FDA Tightens The Line As Category 2 Pushes Toward Category 1
Peptides are no longer operating in the background of compounding pharmacy practice. They are now front and center, and more importantly, under a level of scrutiny that should not be underestimated...
Buchanan Ingersoll & Rooney PC
